Category:LBS: Difference between revisions

Latest revision as of 01:15, 26 May 2023

Sphingolipid

Upper classes: LB

Class Overview

Three Sphingolipid categories (LBS) exist in this database.

このデータベースではスフィンゴ脂質を以下に分けています。

		\|	OH
(C₁₄-chain)	＝	／	＼	／	ー	OH
(fatty acid) ー			\|	NH

セラミド

Glycosphingolipid

		\|	OH
(C₁₄-chain)	＝	／	＼	／	ー	O-(sugar)
(fatty acid) ー			\|	NH

スフィンゴ糖脂質

Phosphosphingolipid

		\|	OH
(C₁₄-chain)	＝	／	＼	／	ー	O-(phosphate)
(fatty acid) ー			\|	NH

スフィンゴリン脂質

Long-chain base and ceramide

Sphingomyelin, CPE, CAEP and GIPC

Go to Sphingolipid search.

Sphingolipid

Notation

Symbol Abbreviations (e.g. Glc = glucose)
Backbones
Cer	ceramide	セラミド
Sph	sphingosine	スフィンゴシン
Sugars
Glc	glucose	グルコース
Gal	galactose	ガラクトース
GlcNAc	N-acetyl-glucosamine	N-アセチルグルコサミン
GalNAc	N-acetyl-galactosamine	N-アセチルガラクトサミン
GlcN	glucosamine	グルコサミン
GalN	galactosamine	ガラクトサミン
GlcA	glucuronic acid	グルクロン酸
GalA	galacturonic acid	ガラクツロン酸
Man	mannose	マンノース
Rha	rhamnose (= 6-deoxy-mannose)	ラムノース (6-デオキシマンノース)
Ins	inositol	イノシトール
Fuc	fucose (= 6-deoxy-galactose)	フコース (6-デオキシガラクトース)
Ara	arabinose	アラビノース
Xyl	xylose	キシロース
NeuNH	(deacetyl) neuraminic acid (pyruvate + mannosamine)	ノイラミン酸 (ピルビン酸＋マンノサミン)
NeuAc	N-acetyl-neuraminic acid	N-アセチルノイラミン酸
NeuGc	N-glycolyl-neuraminic acid	N-グリコリルノイラミン酸
Kdn	2-keto-3-deoxy-D-glycero- D-galacto-nononic acid	デアミノノイラミン酸
Modifiers
AEPn	aminoethylphosphonic acid, or (2-aminoethyl)hydroxyphosphoryl-	アミノエチルホスホン酸（C-P結合）
MAEPn	N-methyl aminoethylphosphonic acid, or (N-methyl-2-aminoethyl) hydroxyphosphoryl-	AEPnのN-メチル体（C-P結合）
EtnP	phosphoethanolamine (PEA), or 2-aminoethanolphospho-	ホスホエタノールアミン
PC	Phosphocholine	ホスホコリン
Butenyl	Butenyl	ブテニル基
Me	Methyl	メチル基
Et	Ethyl	エチル基

Page/ID-Code Design

Major series of phosphosphingolipids are determined by molecules bound to their phosphates, and the series of glycosphingolipids are determined by oligosaccharides bound to their ceramides. The IUPAC series of glycosphingolipids (1977) were based on the order and bonding patterns of four sugars rooting at the long-chain base. Our series, however, are based on three sugars. Two original series, Echino and Schisto, are also added.

スフィンゴリン脂質はリン酸に結合する分子や糖の種類、スフィンゴ糖脂質はセラミドに結合する糖鎖により系列を作成しています。1977年にIUPACが提唱したスフィンゴ糖脂質の系列は、長鎖塩基に結合する四糖の並びと結合を基準にしています。ここではより広い糖鎖の系列を検索できるよう、三糖を基準に分類しています。また新たにEchinoとSchistoの系列を加えています。

L

B

S

G/P

s1

s2

n1

n2

y

c1

c2

G/P	G (glyco)	P (phospho)
s1, s2	structure code as explained below
n1, n2	number of sugars (2 digits)
y	number of sialic acids (1 digit)
c1, c2	serial numbers

First (s1) Digit for Glycosphingolipid

First sugar

Code

Root sequence

Major Series

Cerebroside

For GalCer and GlcCer, visit this page.

starting with
Galactose

()

Gal-Cer

	Gal_α1-4/6Gal_β1-Cer
	Gal_β1-4Glc_β1-3Gal_β1-Cer

starting with
Glucose

()

GalNAc_β-Gal_β-Glc_β-Cer

	GalNAc_β1-4Gal_β1-4Glc_β1-Cer
^[1]	GalNAc_β1-3Gal_β1-4Glc_β1-Cer
	GlcNAc_β1-3(GalNAc_β1-4)Gal_β1-4Glc_β1-Cer
	GalNAc_β1-4(NeuAc_α2-3)Gal_β1-4Glc_β1-Cer
	GalNAc_β1-4(NeuAc_α2-8NeuAc_α2-3)Gal_β1-4Glc_β1-Cer
	GalNAc_β1-4(NeuAc_α2-8NeuAc_α2-8NeuAc_α2-3)Gal_β1-4Glc_β1-Cer
	...(NeuAc_α2-6)GalNAc_β1-4Gal_β1-4Glc_β1-Cer
	...(NeuAc_α2-8NeuAc_α2-6)GalNAc_β1-4Gal_β1-4Glc_β1-Cer

()

GlcNAc_β-Gal_β-Glc_β-Cer

	Gal_β1-3GlcNAc_β1-3Gal_β1-4Glc_β1-Cer
^[2]	Gal_β1-4GlcNAc_β1-3Gal_β1-4Glc_β1-Cer

()

Gal_α-Gal_β-Glc_β-Cer

	Gal_α1-4Gal_β1-4Glc_β1-Cer
^[1]	Gal_α1-3Gal_β1-4Glc_β1-Cer

()

Gal-Glc-Cer
(Other than G2∼G4)

Gal_β1-4Gal_β1-4Glc_β1-Cer

()

Man-Glc_β-Cer

	GlcNAc_β1-3Man_β1-4Glc_β1-Cer
	Man_α1-3Man_β1-4Glc_β1-Cer

()

NeuAc/NeuGc-Glc_β-Cer

NeuGc or NeuAc_α2-6Glc_β1-Cer

()

GalNAc-Glc-Cer

^[3]	GalNAc_β1-4Glc_β1-Cer

starting with
Other Sugars

Symbols follow the Sugar-digit table.

↑ ^1.0 ^1.1 In IUPAC, "iso" refers to a change from position 4 to position 3.
↑ In IUPAC, "neo" refers to a change from position 3 to position 4.
↑ Makaaru CK, Damian RT, Smith DF, Cummings RD. "The human blood fluke Schistosoma mansoni synthesizes a novel type of glycosphingolipid" J Biol Chem 1992 267:2251-2257 PMID 1733932

First (s1) Digit for Phosphosphingolipid

First sugar

Code

Root sequence

Major Series

No Sugar Attached

P1 (LBSP)

R-P-Cer

Sphingomyelin and Ceramide phosphoetanolamine
(Visit this page.)

starting with
Inositol

(29 items)

GlcN_α/β1−2/6Ins₁-P-Cer

GlcN_α/β1-2/6Ins1-P-Cer

(10 items)

GlcA_α/β1−2/6Ins₁-P-Cer

GlcA_α/β1-2/6Ins1-P-Cer

(52 items)

Man_α/β1−2/6Ins₁-P-Cer

Man_α/β1-2/6Ins1-P-Cer

(21 items)

Gal, Glc, and Others

X-Ins1-P-Cer

Second (s2) Digit

Click to see the full list. For abbreviations, see #Notation.

Code	Structure
A	Glc
B	Gal
C	GlcNAc
D	GalNAc
E	GlcN
F	GalN
G	GlcA
H	GalA
I	not used

Code	Structure
J
K
L
M	Fucose ( , , )
N
O
P
Q
R

Code	Structure
S
T	, ,
U
V	acyl/alkyl/alkenyl chain

Biosynthesis

Sphingosine is synthesized from decarboxylating condensation of palmitoyl CoA with serine on the ER membrane. It is a 18-carbon amino alcohol (16 carbons from palmitic acid and 2 from serine) with one unsaturated bond (trans-form) at the C-4 position (2-amino-4-octadecene-1,3-diol). (more details)

スフィンゴシンはパルミトイルCoAがアミノ酸セリンと脱炭酸縮合して生成します。炭素を18個含むアミノアルコール(16個がパルミチン酸、2個がセリン由来)でトランス型の不飽和結合をC-4に1つ含みます。（詳細はこちら）

History of Sphingolipids

Sphingolipids were first isolated from brain by J.L.W. Thudichum (1829-1901) as lipids of unknown function and structure.^[1] The basic structure is a long-chain base (long-chain amino-alcohol) whose amino-group is acylated with a long-chain fatty acid. This hydrophobic structure is called ceramides. Sphingolipid consists of phospho-sphingolipid and glyco-sphingolipid, whose ceramide structure is bonded with phosphate and (oligo)saccharides, respectively. Phosphosphingolipid includes sphingomyelin, and glycosphingolipid, cerebrosides and gangliosides. Both are abundant in neural tissues.^[2]

スフィンゴ脂質は J.L.W. Thudichum (1829-1901) により機能や構造未知の脂質として脳から見いだされました。基本骨格は長鎖塩基 (長鎖アミノアルコール) のアミノ基が長鎖脂肪酸とアミド結合したもので、セラミドと呼ばれます。スフィンゴ脂質はセラミドにリン酸が結合したスフィンゴリン脂質と糖が結合したスフィンゴ糖脂質に分けられます。スフィンゴリン脂質にはスフィンゴミエリンが、スフィンゴ糖脂質にはセレブロシドやガングリオシドなどが含まれ、いずれも神経系に多く存在します。

↑ Thudichum J.L.W.?"A Treatise on the Chemical Constitution of the Balliere" Tindall and Cox, London,?1884
↑ Gault CR,?Obeid LM,?Hannun YA "An overview of sphingolipid synthesis to breakdown" Adv Exp Med Biol.?2010;688:1-23. PMID 20919643

Subcategories

This category has the following 4 subcategories, out of 4 total.

L

[iso-1] 1.0 ^1.1 In IUPAC, "iso" refers to a change from position 4 to position 3.

[neo-2] In IUPAC, "neo" refers to a change from position 3 to position 4.

[3] Makaaru CK, Damian RT, Smith DF, Cummings RD. "The human blood fluke Schistosoma mansoni synthesizes a novel type of glycosphingolipid" J Biol Chem 1992 267:2251-2257 PMID 1733932

[4] Thudichum J.L.W.?"A Treatise on the Chemical Constitution of the Balliere" Tindall and Cox, London,?1884

[5] Gault CR,?Obeid LM,?Hannun YA "An overview of sphingolipid synthesis to breakdown" Adv Exp Med Biol.?2010;688:1-23. PMID 20919643

[1]

[2]

[3]

[1]

[2]

Category:LBS: Difference between revisions

Latest revision as of 01:15, 26 May 2023

Contents

Class Overview

Sphingolipid

Notation

Page/ID-Code Design

First (s1) Digit for Glycosphingolipid

First (s1) Digit for Phosphosphingolipid

Second (s2) Digit

Biosynthesis

History of Sphingolipids

Subcategories

L

Navigation

Tools

@@ Line 2: / Line 2: @@
 {{LB/Header}}
 {{Hierarchy|{{PAGENAME}}}}
-{| style="float:right"
+{| style="float:left"
 | __TOC__
 |}
-==Class Overview==
+=={{Bilingual|概要|Class Overview}}==
-The Sphingolipid category (LBS) in the database includes glycosphingolipid and phosphosphingolipid.
+{{Twocolumn|
+Three Sphingolipid categories (LBS) exist in this database.
+|このデータベースではスフィンゴ脂質を以下に分けています。
+}}
 <center>
-{| class="wikitable"
+{|
 |-
-! colspan="3" | Sphingolipid Overview
+| style="vertical-align:top" width="33%"|
+[[:Category:LBSB| '''Ceramide''']]<br/>{{LBS/Cer|OH}}<br/><small>セラミド</small>
+| style="vertical-align:top" width="33%"|
+'''Glycosphingolipid'''<br/>{{LBS/Cer|O-(sugar)}}<br/><small>スフィンゴ糖脂質</small>
+| style="vertical-align:top" width="33%"|
+[[:Category:LBSP| '''Phosphosphingolipid''']]<br/>{{LBS/Cer|O-(phosphate)}}<br/><small>スフィンゴリン脂質</small>
 |-
-| align="center" style="vertical-align:top" width=33%|
+|
-Glyco-sphingolipid<br><small>スフィンゴ糖脂質</small>
+*[[:Category:LBSB|Long-chain base and ceramide]]
-<br>[[Image:LBSnn.png|120px]]<br>
+|
-| align="center" style="vertical-align:top" width=33%|
+*[[:Category:LBSC|Cerebroside <small>(monohexosyl ceramides)</small>]]
-Phospho-sphingolipid<br><small>スフィンゴリン脂質</small>
+*[[:Category:LBSG|Acidic glycosphingolipid]]
-<br>[[Image:LBSPP.png|120px]]<br>
+|
+*[[:Category:LBSP|Sphingomyelin, CPE, CAEP and GIPC]]
+|}
+</center>
+<center>
+{| class="wikitable"
+|<big>
+[[:Category:LBS/Search|{{Bilingual|スフィンゴ脂質検索画面にいく|Go to Sphingolipid search.}}]]
+</big>
 |}
 </center>
-==={{Bilingual|スフィンゴシンとセラミド|Sphingosine & Ceramide}}===
-{{Twocolumn|
+=={{Bilingual|スフィンゴ脂質|Sphingolipid}}==
-Sphingolipids were first isolated from brain by J.L.W. Thudichum (1829-1901) as lipids of unknown function and structure. The name "sphingo" comes from the Greek word ''sphingein'' for holding tight. (The Sphinx also comes from this word root. <cite>See [http://en.wikipedia.org/wiki/Sphinx the Wikipedia article] in English.</cite>, as well as sphincter muscle.) The basic structure is a long-chain base, usually sphingosine (2-amino-4-octadecene-1,3-diol), whose amino-group is acylated with a long-chain fatty acid. This hydrophobic structure is called ceramides.
-|
+==={{Bilingual|表記法|Notation}}===
-スフィンゴ脂質は J.L.W. Thudichum (1829-1901) により機能や構造未知の脂質として脳から見いだされました。スフィンゴという名前はギリシャ語の sphingein に由来しており、「固く縛る」という意味です。（スフィンクスの語源も之に同じで、括約筋のことを英語で sphincter muscle といいます。）基本骨格は長鎖塩基 (長鎖アミノアルコール、通常はスフィンゴシン) のアミノ基が長鎖脂肪酸とアミド結合したもので、セラミドと呼ばれます。
+{| class="wikitable collapsible collapsed" style="width:80%"
+!colspan="4" align="center" style="background:lightgray"| Symbol Abbreviations (e.g. Glc = glucose)
+|-
+!colspan="4" align="center" style="background:lightgray"| Backbones
+{{#repeatnum:LBS/AbbrevRow|1|
+Cer && ceramide && セラミド &&
+Sph && sphingosine && スフィンゴシン &&
+}}
+|-
+!colspan="4" align="center" style="background:lightgray"| Sugars
+{{#repeatnum:LBS/AbbrevRow|1|
+Glc && glucose && グルコース && C6H12O6 &&
+Gal && galactose && ガラクトース && C6H12O6 &&
+GlcNAc && ''N''-acetyl-glucosamine && ''N''-アセチルグルコサミン && C8H15NO6
+GalNAc && ''N''-acetyl-galactosamine && ''N''-アセチルガラクトサミン && C8H15NO6
+GlcN && glucosamine && グルコサミン && C6H13NO5
+GalN && galactosamine && ガラクトサミン && C6H13NO5
+GlcA && glucuronic acid && グルクロン酸 && C6H10O7
+GalA && galacturonic acid && ガラクツロン酸 && C6H10O7 &&
+Man && mannose && マンノース && C6H12O6 && 18950
+Rha && rhamnose (= 6-deoxy-mannose) && ラムノース (6-デオキシマンノース) && C6H12O5 && 19233
+Ins && inositol && イノシトール && C6H12O6 && 892
+Fuc && fucose (= 6-deoxy-galactose) && フコース (6-デオキシガラクトース) && C6H12O5 && 17106
+Ara && arabinose && アラビノース && C5H10O5 && 5460291
+Xyl && xylose && キシロース && C5H10O5 && 135191
+NeuNH && (deacetyl) neuraminic acid<br/>(pyruvate + mannosamine) && ノイラミン酸<br/>(ピルビン酸＋マンノサミン) && C9H17N1O8 && 513472
+NeuAc && ''N''-acetyl-neuraminic acid && ''N''-アセチルノイラミン酸 && C11H19NO9 && 439197
+NeuGc && ''N''-glycolyl-neuraminic acid && ''N''-グリコリルノイラミン酸 && C11H19NO10 && 123802
+Kdn && 2-keto-3-deoxy-D-glycero-<br/>D-galacto-nononic acid && デアミノノイラミン酸 && C9H16O9 && 13991616
+}}
+|-
+!colspan="4" align="center" style="background:lightgray"| Modifiers
+{{#repeatnum:LBS/AbbrevRow|1|
+AEPn && aminoethylphosphonic acid, or<br/>(2-aminoethyl)hydroxyphosphoryl- && アミノエチルホスホン酸（C-P結合）
+MAEPn && ''N''-methyl aminoethylphosphonic acid, or<br/>(''N''-methyl-2-aminoethyl) hydroxyphosphoryl- && AEPnの''N''-メチル体（C-P結合）
+EtnP && phosphoethanolamine (PEA), or<br/>2-aminoethanolphospho- && ホスホエタノールアミン
+PC && Phosphocholine && ホスホコリン
+Butenyl && Butenyl && ブテニル基
+Me && Methyl && メチル基
+Et && Ethyl && エチル基
 }}
+|}
+==={{Bilingual|分類体系|Page/ID-Code Design}}===
 {{Twocolumn|
-Ceramides with the sphingosine base are prevalent as membrane components of eukaryotic cells. Those with the phytosphingosine base localize in particular organs such as small intestines. Sphingomyelin is a ceramide with phosphocholine.
+Major series of phosphosphingolipids are determined by molecules bound to their phosphates, and the series of glycosphingolipids are determined by oligosaccharides bound to their ceramides. The IUPAC series of glycosphingolipids (1977) were based on the order and bonding patterns of four sugars rooting at the long-chain base. Our series, however, are based on three sugars. Two original series, Echino and Schisto, are also added.
-|
+|スフィンゴリン脂質はリン酸に結合する分子や糖の種類、スフィンゴ糖脂質はセラミドに結合する糖鎖により系列を作成しています。1977年にIUPACが提唱したスフィンゴ糖脂質の系列は、長鎖塩基に結合する四糖の並びと結合を基準にしています。ここではより広い糖鎖の系列を検索できるよう、三糖を基準に分類しています。また新たにEchinoとSchistoの系列を加えています。
-スフィンゴシンをもつセラミドは細胞組織の膜成分として普遍的に存在します。その他にも臓器特異的にフィトスフィンゴシンを含むセラミドが知られています。セラミドにホスフォコリンがついたものが有名なスフィンゴミエリンです。
 }}
-<!----
+{|
-<center>
+|
+<table border=1>
+<tr>
+<td style="background-color:yellowgreen;" width=20px align="center"><big>L</big>
+<td style="background-color:yellowgreen;" width=20px align="center"><big>B</big>
+<td style="background-color:yellowgreen;" width=20px align="center"><big>S</big>
+<td style="background-color:green;" width=20px align="center"><big>''G/P''</big>
+<td style="background-color:Blue; color:white" width=20px align="center"><big>''s1''</big>
+<td style="background-color:Blue; color:white" width=20px align="center"><big>''s2''</big>
+<td style="background-color:tomato; color:white" width=20px align="center"><big>''n1''</big>
+<td style="background-color:tomato; color:white" width=20px align="center"><big>''n2''</big>
+<td style="background-color:firebrick; color:white" width=20px align="center"><big>''y''</big>
+<td style="background-color:white;" width=20px align="center"><big>''c1''</big>
+<td style="background-color:white;" width=20px align="center"><big>''c2''</big>
+</tr>
+</table>
+| &nbsp;
+|
 {| class="wikitable"
+! '''G/P''' || '''G''' (glyco) || '''P''' (phospho)
 |-
-|
+! '''s1, s2'''
-|colspan="3"| Glycosylceramides
+|colspan="3"| structure code as explained below
-|colspan="3"| Glycosyl inositol phosphorylceramides (GIPCs)
 |-
-|
+! '''n1, n2'''
-|Fatty acid
+|colspan="2"| number of sugars (2 digits)
-|LCB
-|Ref.
-|Fatty acid
-|LCB
-|Ref.
 |-
-|Plant
+! '''y'''
-| h[C16:0 -C26:0] <br/> h[C16:1 -C26:1] <br/> h[C16:0] <br/> h[VLCFA]
+|colspan="2"| number of sialic acids (1 digit)
-| d18:2 <br/> d18:2 <br/> d18:1 <br/> t18:1
-| 1,3<br/>1,3<br/>1<br/>1,3
-| h[VLCFA] <br/> h[C14:0-C26:0] <br/> h[C20:1-C26:1]
-| t18:1 <br/> t18:0/1 <br/> t18:0/1
-| 1 <br/> 4 <br/> 1,4
 |-
-|Fungi
+! '''c1, c2'''
-| h[C16:0 - C18:0] <br/> h[C16:1- C18:1]
+|colspan="2"| serial numbers
-| 9-methyl d18:2 <br/> 9-methyl d18:2
+|}
-| 2,3<br/>2,3
-| C24:1 - C26:1 <br/> h[C24:0 - C26:0] <br/>  h[C16:0 - C26:0]
-| t18:0 <br/> t18:0 <br/> t18:0, t20:0
-| 2 <br/> 3 <br/> 3,4
 |}
-<small>LCB: long chain base, h: hydroxy, VLCFA: very long chain fatty acid</small>
-</center>
---->
+==={{Bilingual|スフィンゴ糖脂質１文字目|First (s1) Digit for Glycosphingolipid}}===
+<span id="SphingolipidClass"></span>
+{| class="wikitable" style="text-align:right; background-color:white"
+! First sugar || Code || Root sequence
+! colspan=2 | Major Series
+|-
+! Cerebroside
+| colspan="3" style="text-align:left" | '''For GalCer and GlcCer, visit [[:Category:LBSC|this page]].'''
+|-
+! starting with<br/><big>Galactose</big>
+| {{#volatile:ListMol/LBStitle|<b>G1</b>|LBSG1}} <br /> ({{#volatile:ClassMatrix|{{#countTitle:LBSG1}} items|LBSG1.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids}})
+|style="text-align:right"| '''Gal'''-Cer
+|
+{| style="width:100%;"
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Gala / Neogala|Mainchain.*Gala1-4?6?Galb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Gala1-4/6Galb1-Cer}}
+|-
+|style="border:0;text-align:left"|{{#volatile:ListMol/LBS|Spirometo|Mainchain.*Galb1-4Glcb1-3Galb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Galb1-4Glcb1-3Galb1-Cer}}
+|}
+|-
+! rowspan="8" | starting with<br/><big>Glucose</big>
+|-
+| {{#volatile:ListMol/LBStitle|<b>G2</b>|LBSG2}} <br /> ({{#volatile:ClassMatrix|{{#countTitle:LBSG2}} items|LBSG2.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids}})
+|style="text-align:right"| '''GalNAc<sub>&beta;</sub>'''-Gal<sub>&beta;</sub>-Glc<sub>&beta;</sub>-Cer
+|
+{| style="width:100%"
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Ganglio|Mainchain.*GalNAcb1-4Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-4Galb1-4Glcb1-Cer}}
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Isoganglio|Mainchain.*GalNAcb1-3Galb1-4Glcb1-Cer}}<ref name="iso">In IUPAC, "iso" refers to a change from position 4 to position 3.</ref>
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-3Galb1-4Glcb1-Cer}}
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Lactoganglio|Structure.*GlcNAcb1-3\(.*GalNAcb1-4\)Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GlcNAcb1-3(GalNAcb1-4)Galb1-4Glcb1-Cer}}
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|a-series|Structure.*\(?NeuAca2-3\)?Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-4(NeuAca2-3)Galb1-4Glcb1-Cer}}
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|b-series|Structure.*\(?NeuAca2-8NeuAca2-3\)?Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-4(NeuAca2-8NeuAca2-3)Galb1-4Glcb1-Cer}}
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|c-series|Structure.*\(?NeuAca2-8NeuAca2-8NeuAca2-3\)?Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-4(NeuAca2-8NeuAca2-8NeuAca2-3)Galb1-4Glcb1-Cer}}
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|&alpha;-series|Structure.*\(?NeuAca2-6\)?GalNAcb1-4Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|...(NeuAca2-6)GalNAcb1-4Galb1-4Glcb1-Cer}}
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|&beta;-series|Structure.*\(?NeuAca2-8NeuAca2-6\)?GalNAcb1-4Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|...(NeuAca2-8NeuAca2-6)GalNAcb1-4Galb1-4Glcb1-Cer}}
+|}
+|-
+| {{#volatile:ListMol/LBStitle|<b>G3</b>|LBSG3}} <br /> ({{#volatile:ClassMatrix|{{#countTitle:LBSG3}} items|LBSG3.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids}})
+|style="text-align:right"| '''GlcNAc<sub>&beta;</sub>'''-Gal<sub>&beta;</sub>-Glc<sub>&beta;</sub>-Cer
+|
+{| style="width:100%"
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Lacto|Mainchain.*Galb1-3GlcNAcb1-3Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Galb1-3GlcNAcb1-3Galb1-4Glcb1-Cer}}
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Neolacto|Mainchain.*Gal.1-4GlcNAcb1-3Galb1-4Glcb1-Cer}}<ref name="neo">In IUPAC, "neo" refers to a change from position 3 to position 4.</ref>
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Galb1-4GlcNAcb1-3Galb1-4Glcb1-Cer}}
+|}
+|-
+| {{#volatile:ListMol/LBStitle|<b>G4</b>|LBSG4}} <br /> ({{#volatile:ClassMatrix|{{#countTitle:LBSG4}} items|LBSG4.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids}})
+|style="text-align:right"| '''Gal<sub>&alpha;</sub>'''-Gal<sub>&beta;</sub>-Glc<sub>&beta;</sub>-Cer
+|
+{| style="width:100%"
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Globo|Mainchain.*Gala1-4Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Gala1-4Galb1-4Glcb1-Cer}}
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Isoglobo|Mainchain.*Gala1-3Galb1-4Glcb1-Cer}}<ref name="iso"/>
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Gala1-3Galb1-4Glcb1-Cer}}
+|}
+|-
+| {{#volatile:ListMol/LBStitle|<b>G5</b>|LBSG5}} <br /> ({{#volatile:ClassMatrix|{{#countTitle:LBSG5}} items|LBSG5.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids}})
+|style="text-align:right"| Gal-Glc-Cer<br/>(Other than G2&sim;G4)
+|
+{| style="width:100%"
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Muco|Mainchain.*Galb1-4Galb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Galb1-4Galb1-4Glcb1-Cer}}
+|}
+|-
+| {{#volatile:ListMol/LBStitle|<b>G6</b>|LBSG6}} <br /> ({{#volatile:ClassMatrix|{{#countTitle:LBSG6}} items|LBSG6.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids}})
+|style="text-align:right"| '''Man'''-Glc<sub>&beta;</sub>-Cer
+|
+{| style="width:100%"
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Arthro|Mainchain.*GlcNAcb1-3Manb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GlcNAcb1-3Manb1-4Glcb1-Cer}}
+|-
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Mollu|Mainchain.*Mana1-3Manb1-4Glcb1-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Mana1-3Manb1-4Glcb1-Cer}}
+|}
+|-
+| {{#volatile:ListMol/LBStitle|<b>G7</b>|LBSG7}} <br /> ({{#volatile:ClassMatrix|{{#countTitle:LBSG7}} items|LBSG7.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids}})
+|style="text-align:right"| '''NeuAc'''/'''NeuGc'''-Glc<sub>&beta;</sub>-Cer
+|
+{| style="width:100%"
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Echino|Mainchain.*Neu(A~G)c.2-6Glcb1-Cer}}
+|style="border:0;text-align:right"| <font color=purple>'''NeuGc'''</font> or {{#invoke:LBS|FormatSugar|NeuAca2-6Glcb1-Cer}}
+|}
+|-
+| {{#volatile:ListMol/LBStitle|<b>G8</b>|LBSG8}} <br /> ({{#volatile:ClassMatrix|{{#countTitle:LBSG8}} items|LBSG8.....|7|8|9|9|Number_of_Sugars|Number_of_Sialic_acids}})
+|style="text-align:right"| '''GalNAc'''-Glc-Cer
+|
+{| style="width:100%"
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Schisto|Mainchain.*GalNAc.1-4Glc.1-Cer}}<ref>Makaaru CK, Damian RT, Smith DF, Cummings RD. "The human blood fluke Schistosoma mansoni synthesizes a novel type of glycosphingolipid" J Biol Chem 1992 267:2251-2257 PMID 1733932</ref>
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GalNAcb1-4Glcb1-Cer}}
+|}
+|-
+! starting with<br/><big>Other Sugars</big>
+| {{#volatile:ListMol/LBStitle|<b>G</b>(<b>A</b>&sim;<b>R</b>)|LBSG(A~B~C~D~E~F~G~H~J~K~M~N~O~P~Q~R)}}
+|colspan="2"| Symbols follow the Sugar-digit table.
+|}
 <references/>
-==Biosynthesis==
+==={{Bilingual|スフィンゴリン脂質１文字目|First (s1) Digit for Phosphosphingolipid}}===
-{{Twocolumn|
+{| class="wikitable" style="text-align:right; background-color:white"
-Sphingosine is synthesized from decarboxylating condensation of palmitoyl CoA with serine.  It is a 18-carbon amino alcohol (16 carbons from palmitic acid and 2 from serine) with one unsaturated bond.
+! First sugar || Code || Root sequence
+!colspan="2"| Major Series
+|-
+! No Sugar Attached
+| '''P1''' ([[:Category:LBSP|LBSP]])
+| R-P-Cer
+| Sphingomyelin and Ceramide phosphoetanolamine<br/>(Visit [[:Category:LBSP|this page]].)
+|-
+! rowspan="4" | starting with<br/><big>Inositol</big>
+| {{#volatile:ListMol/LBStitle|<b>P2</b>|LBSP2}} <br /> ({{#countTitle:LBSP2}} items)
+| style="text-align:right"| '''GlcN'''<sub>&alpha;/&beta;1&minus;2/6</sub>Ins<sub>1</sub>-P-Cer
+|
+{|style="width:100%"
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Protozoa & Fungi-specific|Mainchain.*GlcN.1-.Ins-P-Cer}}
+| style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GlcNa/b1-2/6Ins1-P-Cer}}
+|}
+|-
+| {{#volatile:ListMol/LBStitle|<b>P3</b>|LBSP3}} <br /> ({{#countTitle:LBSP3}} items)
+|style="text-align:right"| '''GlcA'''<sub>&alpha;/&beta;1&minus;2/6</sub>Ins<sub>1</sub>-P-Cer
+|
+{|style="width:100%"
+|style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Plant-specific|Mainchain.*GlcA.1-.Ins-P-Cer}}
+|style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|GlcAa/b1-2/6Ins1-P-Cer}}
+|}
+|-
+| {{#volatile:ListMol/LBStitle|<b>P4</b>|LBSP4}} <br /> ({{#countTitle:LBSP4}} items)
+| style="text-align:right"| '''Man'''<sub>&alpha;/&beta;1&minus;2/6</sub>Ins<sub>1</sub>-P-Cer
 |
-スフィンゴシンはパルミトイルCoAがアミノ酸セリンと脱炭酸縮合して生成します。炭素を18個含むアミノアルコール(16個がパルミチン酸、2個がセリン由来)で不飽和結合を1つ含んでいます (2-amino-4-octadecene-1,3-diol)。
+{| style="width:100%"
-}}
+| style="border:0;text-align:left"| {{#volatile:ListMol/LBS|Fungi-specific|Mainchain.*Man.1-.Ins-P-Cer}}
+| style="border:0;text-align:right"| {{#invoke:LBS|FormatSugar|Mana/b1-2/6Ins1-P-Cer}}
+|}
+|-
+| {{#volatile:ListMol/LBStitle|<b>P5</b>|LBSP5}} <br /> ({{#countTitle:LBSP5}} items)
+| style="text-align:right"| Gal, Glc, and Others
+| style="text-align:right"| {{#invoke:LBS|FormatSugar|X-Ins1-P-Cer}}
+|}
+==={{Bilingual|コード２文字目|Second (s2) Digit}}===
+<span id="SphingolipidSugar"></span>
+{{Bilingual|クリックすると一覧が出ます。記号の略称については|Click to see the full list. For abbreviations, see}} [[#Notation]].
-==Glycosphingolipid スフィンゴ糖脂質==
+{|
-==={{Bilingual|よく使う略称|Common Abbreviations}}===
+|-
-{| class="collapsible collapsed"
+| valign="top"|
-!colspan="4" align="center" style="background:lightgray"| Sugar Abbreviations (e.g. Glc = glucose)
+{| class="wikitable"
-{{#repeatnum:LBS/AbbrevRow|1|
+|-
-Cer && ceramide && セラミド
+! Code || Structure
-Sph && sphingosine && スフィンゴシン
+|-
-Glc && glucose && グルコース
+! '''A'''
-Gal && galactose && ガラクトース
+| Glc [[File:LBS-Monomer-Glc.png]]
-GlcNAc && ''N''-acetyl-glucosamine && ''N''-アセチルグルコサミン
+|-
-GalNAc && ''N''-acetyl-galactosamine && ''N''-アセチルガラクトサミン
+! '''B'''
-GlcN && glucosamine && グルコサミン
+| Gal [[File:LBS-Monomer-Gal.png]]
-GalN && galactosamine && ガラクトサミン
+|-
-GlcA && glucuronic acid && グルクロン酸
+! '''C'''
-GalA && galacturonic acid && ガラクツロン酸
+| GlcNAc [[File:LBS-Monomer-GlcNAc.png]]
-Man && mannose && マンノース
+|-
-Rha && rhamnose (= 6-deoxy-mannose) && ラムノース (6-デオキシマンノース)
+! '''D'''
-Ins && inositol && イノシトール
+| GalNAc [[File:LBS-Monomer-GalNAc.png]]
-Fuc && fucose (= 6-deoxy-galactose) && フコース (6-デオキシガラクトース)
+|-
-Ara && arabinose && アラビノース
+! '''E'''
-Xyl && xylose && キシロース
+| GlcN [[File:LBS-Monomer-GlcN.png]]
-NeuNH && (deacetyl) neuraminic acid<br/>(pyruvate + mannosamine) && ノイラミン酸<br/>(ピルビン酸＋マンノサミン)
+|-
-NeuAc && ''N''-acetyl-neuraminic acid && ''N''-アセチルノイラミン酸
+! '''F'''
-NeuGc && ''N''-glycolyl-neuraminic acid && ''N''-グリコリルノイラミン酸
+| GalN [[File:LBS-Monomer-GalN.png]]
-KDN && 2-keto-3-deoxy-D-glycero-<br/>D-galacto-nononic acid && デアミノノイラミン酸
+|-
-}}
+! '''G'''
+| GlcA [[File:LBS-Monomer-GlcA.png]]
+|-
+! '''H'''
+| GalA [[File:LBS-Monomer-GalA.png]]
+|-
+! '''I'''
+| not used
+|}
+|valign="top"|
+{| class="wikitable"
+|-
+! Code || Structure
+|-
+! '''J'''
+| {{#volatile:ListMol/LBS|Mannose|Structure.*Man}} [[File:LBS-Monomer-Man.png]]
+|-
+! '''K'''
+| {{#volatile:ListMol/LBS|Rhamnose|Structure.*Rha}} [[File:LBS-Monomer-Rha.png]]
+|-
+! '''L'''
+| {{#volatile:ListMol/LBS|Inositol|Structure.*Ins(Me)?-P-[^Cer]}}
+|-
+! '''M'''
+| Fucose ({{#volatile:ListMol/LBS| 1|Structure[^F]+Fuc[^F]+$}}, {{#volatile:ListMol/LBS|2|Structure([^F]+Fuc){2}[^F]+$}}, {{#volatile:ListMol/LBS|>3|Structure([^F]+Fuc){3} }}) [[File:LBS-Monomer-Fuc.png]]
+|-
+! '''N'''
+| {{#volatile:ListMol/LBS|Arabinose|Structure.*Ara}} [[File:LBS-Monomer-Ara.png]]
+|-
+! '''O'''
+| {{#volatile:ListMol/LBS|Xylose|Structure.*Xyl}} [[File:LBS-Monomer-Xyl.png]]
+|-
+! '''P'''
+| {{#volatile:ListMol/LBS|NeuAc / NeuNH|Structure.*(NeuAc~NeuNH)}} [[File:LBS-Monomer-NeuAc.png]]
+|-
+! '''Q'''
+| {{#volatile:ListMol/LBS|NeuGc|Structure.*(NeuGc)}} [[File:LBS-Monomer-NeuGc.png]]
+|-
+! '''R'''
+| {{#volatile:ListMol/LBS|Kdn|Structure.*(KDN)}} [[File:LBS-Monomer-KDN.png]]
+|}
+|valign="top"|
+{| class="wikitable"
+|-
+! Code || Structure
+|-
+! '''S'''
+| {{#volatile:ListMol/LBS|Phosphate (except GIPC)|Structure.*(Phospho)}} [[File:LBS-Monomer-P.png]]
+|-
+! '''T'''
+| {{#volatile:ListMol/LBS|(M)AEPn|Structure.*(AEPn)}}, {{#volatile:ListMol/LBS|EtnP|Structure.*(EtnP)}}, {{#volatile:ListMol/LBS|PC|Structure.*(PC)}} [[File:LBS-Monomer-AEPn.png]]
+|-
+! '''U'''
+| {{#volatile:ListMol/LBS|Sulfate|Structure.*Sulfo}} [[File:LBS-Monomer-S.png]]
 |-
-!colspan="3" align="center" style="background:lightgray"| Modifiers
+! '''V'''
-{{#repeatnum:LBS/AbbrevRow|1|
+| acyl/alkyl/alkenyl chain [[File:LBS-Monomer-Alkyl.png]]
-AEPn && (2-Aminoethyl)hydroxyphosphoryl &&
+|}
-EtnP && 2-Aminoethanolphospho &&
-MAEPn && (''N''-Methyl-2-aminoethyl)hydroxyphosphoryl &&
+=={{Bilingual|生合成|Biosynthesis}}==
-MAEPr && (''N''-Methyl-2-aminoethyl)phosphoryl &&
+{{Twocolumn|
-HPO3 && Phosphono &&
+Sphingosine is synthesized from decarboxylating condensation of palmitoyl CoA with serine on the ER membrane.  It is a 18-carbon amino alcohol (16 carbons from palmitic acid and 2 from serine) with one unsaturated bond (trans-form) at the C-4 position (2-amino-4-octadecene-1,3-diol). ([[:Category:LBS/Biosynthesis|more details]])
-HSO3 && Sulfono &&
+|
-PC && Phosphocholine &&
+スフィンゴシンはパルミトイルCoAがアミノ酸セリンと脱炭酸縮合して生成します。炭素を18個含むアミノアルコール(16個がパルミチン酸、2個がセリン由来)でトランス型の不飽和結合をC-4に1つ含みます。（[[:Category:LBS/Biosynthesis|詳細はこちら]]）
-CH3CH2CH=CH && Butenyl &&
-Me && Methyl &&
-Et && Ethyl &&
 }}
-|}
-==={{Bilingual|ID番号 (ページタイトル) の設計 |Page/ID Design for Sphingolipid}}===
-<center>
-<table border=1>
+=={{Bilingual|スフィンゴ脂質の歴史|History of Sphingolipids}}==
-<tr>
-<td style="background-color:yellowgreen;" width=15px align="center"><big>L</big>
-<td style="background-color:yellowgreen;" width=15px align="center"><big>B</big>
-<td style="background-color:darkseagreen;" width=15px align="center"><big>S</big>
-<td style="background-color:Blue; color:white" width=15px align="center"><big>''s1''</big>
-<td style="background-color:Blue; color:white" width=15px align="center"><big>''s2''</big>
-<td style="background-color:Blue; color:white" width=15px align="center"><big>''s3''</big>
-<td style="background-color:tomato; color:white" width=15px align="center"><big>''n1''</big>
-<td style="background-color:tomato; color:white" width=15px align="center"><big>''n2''</big>
-<td style="background-color:tan; color:white" width=15px align="center"><big>''d''</big>
-<td style="background-color:firebrick; color:white" width=15px align="center"><big>''y''</big>
-<td style="background-color:white;" width=15px align="center"><big>''c1''</big>
-<td style="background-color:white;" width=15px align="center"><big>''c2''</big>
-</tr>
-</table>
-</center>
 {{Twocolumn|
-* '''s1 &sim; s3''' ... Structure code (3 digits)
+Sphingolipids were first isolated from brain by J.L.W. Thudichum (1829-1901) as lipids of unknown function and structure.<ref>Thudichum J.L.W.?"A Treatise on the Chemical Constitution of the Balliere" Tindall and Cox, London,?1884</ref> The basic structure is a long-chain base (long-chain amino-alcohol) whose amino-group is acylated with a long-chain fatty acid. This hydrophobic structure is called ceramides.
-: Explained below
+Sphingolipid consists of phospho-sphingolipid and glyco-sphingolipid, whose ceramide structure is bonded with phosphate and (oligo)saccharides, respectively. Phosphosphingolipid includes sphingomyelin, and glycosphingolipid, cerebrosides and gangliosides. Both are abundant in neural tissues.<ref>Gault CR,?Obeid LM,?Hannun YA "An overview of sphingolipid synthesis to breakdown" Adv Exp Med Biol.?2010;688:1-23. PMID 20919643</ref>
-* '''n1, n2''' ... the number of sugars (2 digits)
-* '''d''' ... distribution ('''V'''ertebrate; '''I'''nvertebrate; '''N''' both; '''P'''lant; '''C'''hemical synthesis) (1 digit)
-* '''y''' ... the number of sialic acids ( 1 digit)
-* '''c1, c2''' ... serial numbers
 |
-* '''s1 &sim; s3''' ... 構造コード (3桁）
+スフィンゴ脂質は J.L.W. Thudichum (1829-1901) により機能や構造未知の脂質として脳から見いだされました。基本骨格は長鎖塩基 (長鎖アミノアルコール) のアミノ基が長鎖脂肪酸とアミド結合したもので、セラミドと呼ばれます。
-:下に詳述
+スフィンゴ脂質はセラミドにリン酸が結合したスフィンゴリン脂質と糖が結合したスフィンゴ糖脂質に分けられます。スフィンゴリン脂質にはスフィンゴミエリンが、スフィンゴ糖脂質にはセレブロシドやガングリオシドなどが含まれ、いずれも神経系に多く存在します。
-* '''n1, n2''' ... 糖の数 (2桁)
-* '''d''' ... 分布 (V 脊椎; I 無脊椎; N 両方; P 植物; C 合成品)  (1桁)
-* '''y''' ... シアル酸の数 (1桁)
-* '''c1, c2''' ... 通し番号
 }}
-==={{Bilingual|構造コード表|Structure Code}}===
+<references/>
+<!---
 {|
 |valign="top"|
@@ Line 171: / Line 406: @@
 | '''1'''
 |rowspan="3"| <b>Galactose</b><br/>(&alpha; form)
-| {{LBS/FormatSugar|Gala1-3 ...}}
+| {{#invoke:LBS|FormatSugar|Gala1-3 ...}}
 |-
-| '''2''' || {{LBS/FormatSugar|Gala1-4 ...}}
+| '''2''' || {{#invoke:LBS|FormatSugar|Gala1-4 ...}}
 |-
-| '''3''' || {{LBS/FormatSugar|Gala1-6 ...}}
+| '''3''' || {{#invoke:LBS|FormatSugar|Gala1-6 ...}}
 |-
 | '''4'''
 |rowspan="3"| <b>Galactose</b><br/>(&beta; form)
-| {{LBS/FormatSugar|Galb1-3 ...}}
+| {{#invoke:LBS|FormatSugar|Galb1-3 ...}}
 |-
-| '''5''' || {{LBS/FormatSugar|Galb1-4 ...}}
+| '''5''' || {{#invoke:LBS|FormatSugar|Galb1-4 ...}}
 |-
-| '''6''' || {{LBS/FormatSugar|Galb1-6 ...}}
+| '''6''' || {{#invoke:LBS|FormatSugar|Galb1-6 ...}}
 |}
 |valign="top"|
@@ Line 193: / Line 428: @@
 | '''7'''
 |rowspan="3"| <b>''N''-Acetyl Galactosamine</b><br/>(&beta; form)
-| {{LBS/FormatSugar|GalNAcb1-3 ...}}
+| {{#invoke:LBS|FormatSugar|GalNAcb1-3 ...}}
 |-
-| '''8''' || {{LBS/FormatSugar|GalNAcb1-4 ...}}
+| '''8''' || {{#invoke:LBS|FormatSugar|GalNAcb1-4 ...}}
 |-
-| '''9''' || {{LBS/FormatSugar|GalNAcb1-6 ...}}
+| '''9''' || {{#invoke:LBS|FormatSugar|GalNAcb1-6 ...}}
 |-
 | '''A'''
 |rowspan="3"| <b>''N''-Acetyl Glucosamine</b><br/>(&beta; form)
-| {{LBS/FormatSugar|GlcNAcb1-3 ...}}
+| {{#invoke:LBS|FormatSugar|GlcNAcb1-3 ...}}
 |-
 | '''B'''
-| {{LBS/FormatSugar|GlcNAcb1-4 ...}}
+| {{#invoke:LBS|FormatSugar|GlcNAcb1-4 ...}}
 |-
 | '''C'''
-| {{LBS/FormatSugar|GlcNAcb1-6 ...}}
+| {{#invoke:LBS|FormatSugar|GlcNAcb1-6 ...}}
 |}
 |}
@@ Line 220: / Line 455: @@
 | '''D'''
 |rowspan="2"| <b>Aminated Sugars</b><br/>(Except for Code 7&sim;C)
-| {{LBS/FormatSugar|GalNAc, GalN}}
+| {{#invoke:LBS|FormatSugar|GalNAc, GalN}}
 |-
-| '''E''' || {{LBS/FormatSugar|GlcNAc, GlcN}}
+| '''E''' || {{#invoke:LBS|FormatSugar|GlcNAc, GlcN}}
 |-
 | '''F'''
@@ Line 245: / Line 480: @@
 | '''M''' || Mannose and Rhamnose (= 6-deoxymannose)<br/>(<span style="color:green"><b>Man, Rha</b></span>)
 |-
-| '''N''' || Sialic acids<br/>(<b><span style="color:Purple">NeuAc, NeuNH</span>, <span style="color:gray">NeuGc</span>, <span style="color:Green">KDN</span></b>)
+| '''N''' || Sialic acids<br/>(<b><span style="color:Purple">NeuAc, NeuNH</span>, <span style="color:gray">NeuGc</span>, <span style="color:Green">Kdn</span></b>)
 |}
 |}
@@ Line 266: / Line 501: @@
 !colspan="2"| Abbreviations
 |-
-| '''Y''' || {{LBS/FormatSugar|GlcNAcb1-3Manb1-4Glcb1-1Cer}}
+| '''Y''' || {{#invoke:LBS|FormatSugar|GlcNAcb1-3Manb1-4Glcb1-1Cer}}
 |-
-| '''Z''' || {{LBS/FormatSugar|Galb1-4Glcb1-1bCer}}
+| '''Z''' || {{#invoke:LBS|FormatSugar|Galb1-4Glcb1-1bCer}}
 |}
 |}
 ==={{Bilingual|よく知られたパターン|Common Patterns}}===
@@ Line 353: / Line 590: @@
 | 8 || {{MapLink|ListMol|LBS.....V8|LBS.....V8}} || {{MapLink|ListMol|LBS.....I8|LBS.....I8}}
 |}
+--->